Thailand Embryo Donation Technology: Eligible Candidates, Procedure Steps, and Medical Risks Explained
Opening: Test report scenario
▎A test report showing AMH 0.3 ng/mL, FSH 18.5 IU/L, age 42, two failed IVF cycles, and no viable embryos for transfer. This is a typical clinical scenario requiring careful evaluation of embryo donation technology.
1. Basic Concepts and Eligibility Criteria for Embryo Donation
Embryo donation technology refers to the medical technique of using frozen embryos voluntarily donated by a third-party couple after completing their own assisted reproductive treatment. After rigorous medical screening and legal procedures, these embryos are transferred into the recipient's uterus to achieve pregnancy. This technology is not a first-line treatment but is considered only under specific medical indications.
When is embryo donation considered suitable?
- Repeated IVF failure (≥3 transfers of good quality embryos without pregnancy), after excluding uterine and immunological factors, with no viable embryos remaining.
- Advanced maternal age (≥40 years) or severely diminished ovarian reserve (AMH < 0.5 ng/mL), with difficulty retrieving eggs or persistently poor embryo quality.
- One or both partners have a clear risk of genetic disease, and no transferable embryos can be obtained through PGT.
- The female partner cannot produce eggs due to premature ovarian failure, gonadal dysgenesis, or iatrogenic loss of ovarian function.
- Repeatedly high rates of embryo chromosomal aneuploidy (e.g., embryo chromosome abnormality rate > 70% due to advanced age).
From a medical perspective, the core logic of embryo donation is: only when the persistent unavailability of one's own embryos is fully confirmed, and other interventions (such as egg donation, PGT, uterine conditioning, etc.) have been evaluated or attempted, is embryo donation proposed as a reasonable path. It is not a technology that can be chosen arbitrarily, but a solution for specific fertility dilemmas.
2. Why Does the Situation of "No Viable Embryos" Occur?
Clinically, the core problem for individuals needing embryo donation is "the need for embryos but the inability to obtain viable ones." The medical reasons leading to this situation mainly include the following categories:
- Diminished Ovarian Reserve: AMH below 0.5 ng/mL, FSH above 12 IU/L, antral follicle count (AFC) less than 5, resulting in very few or no eggs retrieved after ovarian stimulation.
- Declining Egg Quality: Age-related decline in egg mitochondrial function and meiotic abnormalities, leading to a sharp increase in the rate of embryonic chromosomal aneuploidy. The proportion of euploid embryos in women over 40 is typically less than 20%.
- Poor Embryo Developmental Potential: Even if blastocysts form, repeated failure of hatching, poor inner cell mass quality, or low trophectoderm cell grading prevents them from meeting transfer or freezing standards.
- Genetic Factors: The couple carries pathogenic gene variants, and after PGT screening, all embryos show genetic abnormalities, leaving no transferable embryos.
- Repeated Implantation Failure: After excluding uterine factors, multiple transfers of good quality embryos still fail to result in pregnancy. This may be related to abnormal embryo-endometrial dialogue or occult immunological factors, but the final outcome is a lack of viable remaining embryos.
These causes often overlap, especially in older individuals. Before recommending embryo donation, doctors will systematically investigate the above factors to ensure no reversible or treatable aspects have been overlooked.
3. Differences in Considerations for Women of Different Ages
Age is a core variable affecting the need for and outcome of embryo donation. Women of different ages have significant differences in the reasons for suitability, key evaluation points, and expected outcomes.
| Age Group | Primary Reasons for Suitability | Key Evaluation Points | Special Considerations |
|---|---|---|---|
| < 35 years | Genetic disease risk, repeated implantation failure, premature ovarian failure | Genetic counseling, PGT indications, immunological factors | Need to rule out treatable endometrial factors; higher intensity of psychological assessment |
| 35–39 years | Declining ovarian reserve, increased embryo chromosome abnormality rate, repeated IVF failure | AMH, FSH, AFC, embryo chromosome analysis | Need to compare pros and cons with egg donation option |
| 40–43 years | Ovarian function decline, difficulty retrieving eggs, poor embryo quality | Uterine receptivity, endometrial thickness, blood flow assessment | Increased risk of pregnancy complications; need to evaluate overall health status |
| > 43 years | Own embryos almost unusable, end of advanced maternal age fertility window | Cardiovascular function, metabolic indicators, uterine morphology | Recommend concurrent ethical consultation and legal documentation |
For women under 35 needing embryo donation, genetic factors are more prominent. It is recommended to complete detailed genetic counseling and verification of the donated embryo's genetic information before transfer. For those over 40, more attention should be paid to uterine receptivity and overall health status, as risks of pregnancy complications like hypertension and diabetes increase with age.
4. The Actual Process of Embryo Donation in Thailand
In Thailand, embryo donation technology is regulated by the "Assisted Reproductive Technology Act" and related ethical guidelines. The process emphasizes medical indication review, informed consent, and transparency of genetic information. The following are the standardized steps:
- Medical Evaluation and Indication Confirmation: The recipient must undergo a comprehensive fertility assessment, including hormone panel (FSH, LH, E2, etc.), AMH, ultrasound, hysteroscopy to evaluate the endometrium, and genetic counseling. This confirms that the recipient cannot obtain viable embryos on their own.
- Donated Embryo Screening and Matching: Donated embryos come from voluntarily donated surplus IVF embryos. They must undergo infectious disease screening (HIV, Hepatitis B, Hepatitis C, Syphilis, etc.), genetic information registration, and embryo grading. The recipient can learn basic medical information about the donors (e.g., age, blood type, physical characteristics) but not identifying information.
- Legal Agreement Signing: For embryo donation in Thailand, the recipient and the donor (or the donor through the fertility center) must sign a clear legal agreement. This includes the donor relinquishing all ownership and parental rights to the embryo, and the recipient assuming all legal and medical responsibilities. The agreement must be reviewed by independent legal counsel for both parties.
- Hysteroscopy and Endometrial Preparation: Before transfer, a hysteroscopy is performed to rule out factors affecting implantation, such as endometrial polyps, adhesions, or chronic endometritis. Then, an endometrial preparation cycle begins, using a hormone replacement therapy (HRT) or natural cycle protocol, aiming for an endometrial thickness of ≥7 mm with good blood flow signals.
- Embryo Thawing and Transfer: Blastocyst thawing and transfer are performed on day 5 or 6 after endometrial transformation. Some Thai laboratories use vitrification technology, achieving survival rates over 95%. The transfer is performed under ultrasound guidance, followed by luteal phase support.
- Post-Transfer Management and Pregnancy Confirmation: A blood hCG test is performed 9–11 days after transfer to confirm pregnancy. If pregnant, luteal support continues until 8–10 weeks of gestation, then gradually tapers. An NT scan is performed at 12 weeks, followed by routine prenatal care.
Throughout the process, Thai fertility centers require the recipient to provide complete previous treatment records and recommend staying in Thailand for at least 15–20 days to complete the endometrial preparation and transfer. Some centers support remote endometrial preparation protocols, but this requires prior confirmation of the laboratory's coordination capabilities.
5. Timeline and Cycle Planning
The overall timeline for embryo donation is relatively manageable, but compared to a standard IVF cycle, it includes additional steps for legal agreement signing and donated embryo screening. Below is a typical timeline reference:
| Stage | Time Required | Key Actions |
|---|---|---|
| Initial Evaluation & Counseling | 2–4 weeks | Complete medical tests, genetic counseling, initial legal consultation |
| Donated Embryo Screening & Matching | 1–4 weeks | Wait for suitable donated embryo; verify genetic information |
| Legal Agreement Signing | 1–2 weeks | Independent legal counsel review for both parties; sign formal documents |
| Hysteroscopy | 1 day (outpatient) | Can be completed during the initial evaluation phase |
| Endometrial Preparation Cycle | 12–16 days | Hormone replacement or natural cycle; monitor endometrial thickness and hormone levels |
| Embryo Thawing & Transfer | 1 day | Ultrasound-guided transfer; bed rest for 1–2 hours post-procedure |
| Post-Transfer Observation | 9–11 days | Blood hCG test; continue luteal support if pregnancy is confirmed |
From the start of evaluation to completing the transfer, it typically takes 6–10 weeks. If donated embryo matching goes smoothly and the legal process is efficient, the cycle can be shortened to about 5 weeks. It is recommended that recipients plan their work and travel in advance to ensure sufficient time in Thailand.
6. Most Commonly Overlooked Details
In the clinical practice of embryo donation, several details are often overlooked but have a significant impact on the final outcome.
Some centers only provide embryo grading, not the donor's genetic screening records. Recipients should explicitly request to see the donor's carrier screening results (e.g., for thalassemia, SMA, deafness genes, etc.) before transfer. If information is incomplete, consider PGT re-testing.
The agreement must clearly state: the donor will not claim custody or visitation rights to the embryo or future child under any circumstances; the recipient has full disposal rights over the embryo; and the handling of surplus embryos (destruction, continued freezing, or re-donation) if pregnancy does not occur after transfer.
The infectious disease screening report for donated embryos should be valid within 6 months. If the embryo has been frozen for more than 6 months, some centers require re-screening or supplementary nucleic acid testing (NAT) to rule out window period infections.
For individuals with a history of repeated implantation failure, it is recommended to undergo endometrial receptivity testing (ERA) before transfer to determine if the implantation window is displaced. In standard HRT cycles, about 20%–30% of people have an implantation window different from the conventional time.
Additionally, occult factors in the recipient such as thyroid function, vitamin D levels, and pre-thrombotic state are also easily overlooked. It is recommended to complete a full metabolic and immunological evaluation before transfer.
7. Most Common Pitfalls
Based on practitioner observations, the following three areas are where recipients are most prone to misjudgment or inadequate preparation.
- Neglecting Uterine Cavity Evaluation: Some recipients assume that "as long as the endometrial thickness is sufficient, transfer can proceed," overlooking occult conditions like chronic endometritis (CD138+), endometrial polyps, or intrauterine adhesions. Untreated uterine issues can directly lead to transfer failure. It is recommended to complete hysteroscopy + endometrial biopsy 1–2 months before transfer.
- Overly Optimistic Judgment of Embryo Quality: Donated embryos may have high morphological grades, but grading is primarily based on morphology and does not fully reflect chromosomal status. If the donor was older (e.g., > 35 years), the risk of embryonic chromosomal aneuploidy still exists. It is advisable to confirm whether the embryo has undergone PGT screening; if not, consider pre-transfer genetic testing.
- Insufficient Legal Agreement Signing: For embryo donation in Thailand, the legal agreement must comply with both Thai law and the laws of the recipient's home country (e.g., China). Some recipients rely solely on the template agreement provided by the fertility center without consulting independent legal counsel, leading to obstacles in subsequent steps like child identity determination and nationality registration.
The core strategy to avoid pitfalls is: consult with a reproductive medicine specialist, a genetic counselor, and a cross-border legal advisor before making a decision, ensuring thorough evaluation on both medical and legal fronts.
8. Frequently Asked Questions
1. What is the success rate of donated embryos?
The success rate of embryo donation mainly depends on the quality of the donated embryo and the recipient's uterine receptivity. In Thailand, using vitrified donated blastocysts, the clinical pregnancy rate per single transfer is approximately 45%–65%, and the live birth rate is approximately 35%–50%. Specific figures are influenced by embryo grading, recipient age (uterine factors), and laboratory techniques. It is important to understand that no doctor can guarantee a success rate; any claims guaranteeing success are not in line with medical standards.
2. What is the difference between a donated embryo and one's own embryo?
A donated embryo has no genetic relationship with the recipient, but medically, it still requires assessment of chromosomal euploidy and developmental potential. Compared to one's own embryo, the advantage of a donated embryo is that it bypasses issues of egg quality and genetic disease risk. However, the recipient must psychologically and legally accept the concept of a "non-biological" child. Some centers provide non-identifying information about the donor's physical characteristics and educational background to help the recipient build an emotional connection.
3. What are the legal risks of embryo donation in Thailand?
Thailand's assisted reproductive laws are relatively open, but the legal issues surrounding embryo donation remain complex. Main risks include: the donor potentially changing their mind in the future (despite having waived rights in the agreement), difficulties in establishing the child's legal identity if the recipient's home country does not recognize the Thai legal agreement, and compliance issues regarding cross-border embryo transport. It is recommended to consult both a Thai legal advisor and an immigration or family law attorney in the recipient's home country before starting the process.
4. What is the approximate cost of embryo donation in Thailand?
Costs vary by center, but typically include: embryo screening and management fees, legal agreement fees, recipient examination fees, hysteroscopy fees, endometrial preparation medication fees, embryo thawing and transfer fees, and luteal phase support fees. The total cost is roughly between 80,000 and 150,000 Thai Baht (approximately 1,600 to 3,000 USD), excluding round-trip airfare and accommodation. Some centers offer installment payment plans, but this should be confirmed in advance.
5. What documents are needed?
Recipients need to prepare: passport and visa (non-immigrant visa is sufficient), marriage certificate (if applicable) with a translated and notarized copy, all previous IVF treatment records, hormone test reports, and genetic test reports. For single women, some Thai centers require a legal declaration or ethics committee approval document; specific requirements vary by center.
9. Risk Reminder
▎Important Risk Notice
- Embryo donation cannot completely eliminate the risk of pregnancy complications, including gestational hypertension, diabetes, miscarriage, and preterm birth. The older the recipient, the higher the risk.
- Donated embryos may carry unknown genetic risks. Despite screening, rare mutations or de novo mutations cannot be entirely ruled out.
- The legal agreement is legally binding in Thailand, but if the recipient comes from a country with a different legal system, establishing the child's parent-child relationship and nationality registration may involve additional procedures. It is recommended to have a legal plan in place before transfer.
- Embryo donation involves ethical and psychological adaptation issues. It is recommended that recipients undergo at least 3 psychological counseling sessions before transfer to ensure adequate psychological preparation for raising a "non-biological" child.
- Any claims of "guaranteed success," "zero risk," or "100% healthy" are not credible. Always rely on the written medical documents from a reputable fertility center.
The above content is compiled based on general knowledge of assisted reproductive medicine and the current legal framework in Thailand, for medical decision-making reference. Specific plans should be developed under the joint guidance of a reproductive doctor, genetic counselor, and legal advisor.
